Aspirin - Queensland Ambulance Service
Transcription
Drug Therapy Protocols: Aspirin Disclaimer and copyright ©2016 Queensland Government All rights reserved. Without limiting the reservation of copyright, no person shall reproduce, store in a retrieval system or transmit in any form, or by any means, part or the whole of the Queensland Ambulance Service (‘QAS’) Clinical practice manual (‘CPM’) without the priorwritten permission of the Commissioner. The QAS accepts no responsibility for any modification, redistribution or use of the CPM or any part thereof. The CPM is expressly intended for use by QAS paramedics whenperforming duties and delivering ambulance services for, and on behalf of, the QAS. Under no circumstances will the QAS, its employees or agents, be liable for any loss, injury, claim, liability or damages of any kind resulting from the unauthorised use of, or reliance upon the CPM or its contents. While effort has been made to contact all copyright owners this has not always been possible. The QAS would welcome notification from any copyright holder who has been omitted or incorrectly acknowledged. All feedback and suggestions are welcome, please forward to: Clinical.Guidelines@ambulance.qld.gov.au Date April, 2016 Purpose Scope Author To ensure a consistent procedural approach to Aspirin administration. Applies to all QAS clinical staff. Clinical Quality & Patient Safety Unit, QAS Review date April, 2018 URL https://ambulance.qld.gov.au/clinical.html This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. Aspirin April, 2016 Drug class Precautions Antiplatelet UNCONTROLLED WHEN PRINTED • Possible aortic aneurysm or any other condition that may require surgery[7,8] Pharmacology Aspirin inhibits platelet aggregation by irreversibly inhibiting cyclo-oxygenase, reducing the synthesis of thromboxane A2 (an inducer of platelet aggregation) for the life of the platelet. This action forms the basis of preventing platelets from aggregating to exposed collagen fibres at the site of vascular injury.[1–3] • Pregnancy • History of GI bleeding or peptic ulcers • Concurrent anticoagulant therapy (e.g. warfarin) UNCONTROLLED WHEN PRINTED Metabolism Side effects Aspirin is converted to salicyclic acid in many tissues, but primarily in the GI mucosa and liver. It is subsequently excreted by the kidneys.[1–3] • Epigastric pain/discomfort • Nausea and/or vomiting Indications • Gastritis • GI bleeding UNCONTROLLED WHEN PRINTED • Suspected ACS[4,5] • NSAID induced bronchospasm • Acute cardiogenic pulmonary oedema Contraindications • KSAR or hypersensitivity to aspirin or other NSAIDs UNCONTROLLED WHEN PRINTED • Chest pain associated with psychostimulant overdose[6] • Bleeding OR clotting disorders (e.g. haemophilia) • Current GI bleeding OR peptic ulcers • Patients < 18 years Figure 4.3 QUEENSLAND AMBULANCE SERVICE 727 Aspirin April, 2016 Special notes Presentation UNCONTROLLED WHEN PRINTED • In suspected ACS or acute cardiogenic pulmonary oedema aspirin should be administered following the initial dose of GTN (if indicated). • Tablet (white), 300 mg aspirin • Aspirin administration is indicated for patients with suspected ACS or acute cardiogenic pulmonary oedema, even if pain free. Onset Duration Half-life ≈ 10 minutes (variable) ≈ 1 week (antiplatelet) 3.2 hours (300–650 mg) • Patients who have had < 300 mg aspirin in the previous 24 hours and who present with suspected ACS or acute pulmonary oedema should be administered a dose of aspirin that equates to a total daily dose of 300–450 mg. UNCONTROLLED WHEN PRINTED Schedule • S2 (Therapeutic poisons). Adult dosages UNCONTROLLED WHEN PRINTED P CCP ACP2 P ACP1 • Suspected ACS • Acute cardiogenic pulmonary oedema CCP ACP2 Per oral (PO) ACP1 Routes of administration PO ≥ 18 years – 300 mg Chewed and followed by a small sip of water (where possible).[9] UNCONTROLLED WHEN PRINTED Paediatric dosages Note: QAS officers are NOT authorised to administer aspirin to patients under 18 years of age. QUEENSLAND AMBULANCE SERVICE 728
Similar documents
Clinical Practice Guidelines: Respiratory/Epiglottitis
While effort has been made to contact all copyright owners this has not always been possible. The QAS would welcome notification from any copyright holder who has been omitted or incorrectly acknow...
More informationAcute dystonic reaction - Queensland Ambulance Service
While effort has been made to contact all copyright owners this has not always been possible. The QAS would welcome notification from any copyright holder who has been omitted or incorrectly acknow...
More informationClinical Practice Procedures: Assessment/Glasgow Coma Scale
While effort has been made to contact all copyright owners this has not always been possible. The QAS would welcome notification from any copyright holder who has been omitted or incorrectly acknow...
More informationMetoprolol - Queensland Ambulance Service
Under no circumstances will the QAS, its employees or agents, be liable for any loss, injury, claim, liability or damages of any kind resulting from the unauthorised use of, or reliance upon the CP...
More informationOximetry - Queensland Ambulance Service
While effort has been made to contact all copyright owners this has not always been possible. The QAS would welcome notification from any copyright holder who has been omitted or incorrectly acknow...
More information